DT2216 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: C77H96ClF3N10O10S4

Filter by location:

Boston, Massachusetts1 trial

DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer

Beth Israel Deaconess Medical Center (BIDMC)

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.